Open Access“Reversal” ALPPS in patient with hepatocellular carcinoma and liver cirrhosis. First clinical case in Russia
Author(s) -
С. Э. Восканян,
В. С. Рудаков,
М. В. Шабалин,
А. И. Артемьев,
А. Н. Башков,
И. Ю. Колышев,
А. С. Журбин,
Е. В. Найденов,
М. В. Попов
Publication year - 2021
Publication title -
annaly hirurgičeskoj gepatologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.138
H-Index - 1
eISSN - 2408-9524
pISSN - 1995-5464
DOI - 10.16931/1995-5464.2021-3-142-148
Subject(s) - medicine , hepatectomy , cirrhosis , hepatocellular carcinoma , ligation , resection , parenchyma , liver function , portal vein , surgery , liver parenchyma , radiology , pathology
Liver resection in patients with HCC is the treatment of choice. In patients with insufficient future liver remnant (FLR) and compensated liver function performing the Associated Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS) is possible. The classic version of ALPPS consists in ligation of the right branch of the portal vein with transection of the parenchyma and then performing right hepatectomy or right trisegmentectomy. This paper describes the first case in Russia of performing ligation of the left portal branch with transection of the parenchyma and then performing left trisegmentectomy (“reversal” ALPPS) in a patient with HCC and cirrhosis. Reversal ALPPS can be successfully performed in patients with insufficient future liver remnant in well-selected patients.